HempFusion Wellness Inc (TSE:CBD.U) is entering the European CBD market via a distribution agreement with a leading European company with a wide retail presence.
The Denver-based CBD company announced Thursday that the agreement includes EU-compliant labeling, packaging and distribution for select HempFusion CBD and Probulin Probiotics products.
HempFusion and its European partner will start selling its products in Ireland.
READ: HempFusion Wellness wins USDA Organic Certification for its CBD tinctures
HempFusion’s brands include HempFusion, Probulin Probiotics, Biome Research, and HF Labs. Its product portfolio comprises 46 SKUs including tinctures, over-the-counter topicals, and doctor or practitioner lines.
“We are incredibly excited to launch sales into Europe, starting with Ireland, through an exclusive distribution agreement with a consumer goods distributor whose deep and established relationships include nearly every major European retail chain,” said HempFusion CEO Jason Mitchell in a statement.
“This launch establishes HempFusion’s European presence and represents the initial phase of the company’s broader European expansion plans.”
According to HempFusion, the unnamed distributor has an established presence in the European market, giving HempFusion and Probulin access to the majority of retailers across Ireland. Products will be sold in natural foods stores, pharmacies and eCommerce channels.
HempFusion will launch an initial six brands, comprised of four Probulin and two HempFusion SKUs, with more expected to be added in the first half of 2021.
The company debuted on the Toronto Stock Exchange last week after a US$17 million IPO.
Contact Angela at angela@proactiveinvestors.com
Follow her on Twitter @AHarmantas